SearchDictionaryMobileLogin

Liver-cell adenomas associated with use of oral contraceptives.

AbstractDuring the past six years an increasing number of liver-cell adenomas in women were diagnosed, and we undertook a study of possible etiologic factors, including use of oral contraceptives, in 42 women. There was a significant difference between cases and matched controls in mean months of oral-contraceptive use: 73.4 as compared to 36.2 (P less than 0.001). The women with adenomas took mestranol-containing pills much more commonly than the controls (P less than 0.0001). Hemorrhage into the tumor was often associated with the onset of menstruation in women taking oral contraceptives. Long-term use of oral contraceptives, especially those containing a high total dose of steroids or mestranol as the synthetic estrogen, should be balanced against risks of side effects of the drugs.
AuthorsH A Edmondson, B Henderson, B Benton
JournalThe New England journal of medicine (N Engl J Med) Vol. 294 Issue 9 Pg. 470-2 (Feb 26 1976) ISSN: 0028-4793 UNITED STATES
PMID173996 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Contraceptives, Oral
  • Ethinyl Estradiol
  • Mestranol
Topics
  • Adult
  • Carcinoma, Hepatocellular (chemically induced, pathology)
  • Contraceptives, Oral (adverse effects)
  • Ethinyl Estradiol (adverse effects)
  • Female
  • Humans
  • Liver (pathology)
  • Liver Neoplasms (chemically induced, pathology)
  • Mestranol (adverse effects)
  • Middle Aged
  • Risk
  • Time Factors